<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03132285</url>
  </required_header>
  <id_info>
    <org_study_id>0001</org_study_id>
    <nct_id>NCT03132285</nct_id>
  </id_info>
  <brief_title>Safety and Acceptability Study of PrePex Device When Removing the Foreskin Shortly After Placement of Device</brief_title>
  <official_title>Safety and Acceptability Study of Non-Surgical Male Circumcision Device for Adult Male Population When Removing the Foreskin Shortly After Placement of Device Performed at Lusaka and Livingstone, Zambia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ministry of Health, Zambia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ministry of Health, Zambia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the safety and acceptability of the non-surgical PrePex device among healthy adult
      male participants scheduled for voluntary medical male circumcision when removing the
      foreskin shortly after device placement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess the safety and acceptability of the non-surgical PrePex device among healthy adult
      male participants scheduled for voluntary medical male circumcision when removing the
      foreskin shortly after device placement.

      Five hundred (500) males scheduled for voluntary circumcision performed by clinicians or
      nurses using the PrePex.

      Theses clinicians and nurses have already been trained in the Prepex procedure and will
      undergo further training in the modification to the technique. Study duration per participant
      will be up to 8 weeks and will include three follow up visits and one phone call follow up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 11, 2017</start_date>
  <completion_date type="Actual">June 17, 2017</completion_date>
  <primary_completion_date type="Actual">April 22, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of incidents related to the change in procedure</measure>
    <time_frame>8 weeks</time_frame>
    <description>To assess the safety of PrePex device when removing the foreskin shortly after device placement by means of the following parameter: Incidence of Serious Adverse Events, when performed by clinicians and nurses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability of the changes procedure to patients</measure>
    <time_frame>8 weeks</time_frame>
    <description>To asses the new procedure acceptability for patients using the following measures - Evaluation of pain during foreskin removal
Patients willingness to wait for foreskin removal
Odour while device is in situ
Pain at key time points on Removal visit
Discomfort of any type to patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of the change in procedure on circumcision healing time</measure>
    <time_frame>8 weeks</time_frame>
    <description>To assess the circumcision healing time period.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">500</enrollment>
  <condition>HIV Prevention</condition>
  <arm_group>
    <arm_group_label>PrePex Day 0 foreskin removal</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Day 0 foreskin removal</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PrePex</intervention_name>
    <description>Prepex is a non surgical male circumcision device</description>
    <arm_group_label>PrePex Day 0 foreskin removal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages - 13 to 49 years

          -  Uncircumcised

          -  Participant wants to be circumcised

          -  Participant assent to the procedure

          -  Legal guardian consent to the procedure for ages 13-18 years

          -  Able to understand the study procedures and requirements

          -  Agrees to abstain from sexual intercourse for 8 weeks after circumcision

          -  Agrees to abstain from masturbation for at least 2 weeks after Removal

          -  Agrees to return to the health care facility for follow-up visits (or as instructed)
             after his circumcision for a period of 7 weeks post removal (8 weeks total)

          -  Participant able to comprehend and freely give informed consent for participation in
             this study and is considered by the investigator to have good compliance for the study

        Exclusion Criteria:

          -  Legal guardian withholds consent for ages 13-18 years

          -  Active genital infection, anatomic abnormality or other condition, which in the
             opinion of the investigator prevents the participant from undergoing a circumcision

          -  Participant with the following diseases/conditions: phimosis, paraphimosis, adhesions,
             warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias,
             epispadias

          -  Known bleeding / coagulation abnormality, uncontrolled diabetes

          -  Participant that to the opinion of the investigator is not a good candidate

          -  Diabetes Mellitus

          -  HIV Sero-positive
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Uncircumcised males</gender_description>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Matero Main Clinic</name>
      <address>
        <city>Lusaka</city>
        <state>Lusaka province</state>
        <country>Zambia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dambwa North Clinic</name>
      <address>
        <city>Livingstone</city>
        <country>Zambia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Zambia</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2017</study_first_submitted>
  <study_first_submitted_qc>April 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2017</study_first_posted>
  <last_update_submitted>September 6, 2017</last_update_submitted>
  <last_update_submitted_qc>September 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ministry of Health, Zambia</investigator_affiliation>
    <investigator_full_name>David Linyama</investigator_full_name>
    <investigator_title>General surgeon</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

